Cargando…
Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708220/ https://www.ncbi.nlm.nih.gov/pubmed/26815169 http://dx.doi.org/10.3978/j.issn.2223-4683.2012.11.02 |
| _version_ | 1782409423646359552 |
|---|---|
| author | Heck, Matthias M. Gschwend, Jürgen E. Retz, Margitta |
| author_facet | Heck, Matthias M. Gschwend, Jürgen E. Retz, Margitta |
| author_sort | Heck, Matthias M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4708220 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47082202016-01-26 Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients Heck, Matthias M. Gschwend, Jürgen E. Retz, Margitta Transl Androl Urol Editorial AME Publishing Company 2013-06 /pmc/articles/PMC4708220/ /pubmed/26815169 http://dx.doi.org/10.3978/j.issn.2223-4683.2012.11.02 Text en 2013 Translational Andrology and Urology. All rights reserved. |
| spellingShingle | Editorial Heck, Matthias M. Gschwend, Jürgen E. Retz, Margitta Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients |
| title | Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients |
| title_full | Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients |
| title_fullStr | Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients |
| title_full_unstemmed | Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients |
| title_short | Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients |
| title_sort | enzalutamide (formerly mdv3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708220/ https://www.ncbi.nlm.nih.gov/pubmed/26815169 http://dx.doi.org/10.3978/j.issn.2223-4683.2012.11.02 |
| work_keys_str_mv | AT heckmatthiasm enzalutamideformerlymdv3100prolongssurvivalindocetaxelpretreatedcastrationresistantprostatecancerpatients AT gschwendjurgene enzalutamideformerlymdv3100prolongssurvivalindocetaxelpretreatedcastrationresistantprostatecancerpatients AT retzmargitta enzalutamideformerlymdv3100prolongssurvivalindocetaxelpretreatedcastrationresistantprostatecancerpatients |